CEA-targeted autologous cell vaccine (Dendreon)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameCEA-targeted autologous cell vaccine (Dendreon)
Drug Alias Namecarcinoembryonic antigen-targeted autologous cell immunotherapy (Dendreon)
ClassificationVaccines > Application > Therapeutic vaccineCell and gene therapy > Cell therapy
Mechanisms of ActionCarcinoembryonic antigen related cell adhesion molecule 5 modulators
TargetsCarcinoembryonic antigen related cell adhesion molecule 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDendreon Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDendreon Corp
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A